FAK/PTK2 expression is associated positively with KDR in KIRC, and negatively with PVRL2 in TGCT, HAVCR2, and PDCD1LG2 in BLCA (Fig. 7). This evidence concerns the gene HAVCR2 and bladder transitional cell carcinoma.